Restricted accessResearch articleFirst published online 2015-9
Negative modulation of α 5 GABA A receptors in rats may partially prevent memory impairment induced by MK-801,but not amphetamine- or MK-801-elicited hyperlocomotion
Reportedly, negative modulation of α5 GABAA receptors may improve cognition in normal and pharmacologically-impaired animals, and such modulation has been proposed as an avenue for treatment of cognitive symptoms in schizophrenia. This study assessed the actions of PWZ-029, administered at doses (2, 5, and 10 mg/kg) at which it reached micromolar concentrations in brain tissue with estimated free concentrations adequate for selective modulation of α5 GABAA receptors, in three cognitive tasks in male Wistar rats acutely treated with the noncompetitive N-methyl-d-aspartate receptor antagonist, MK-801 (0.1 mg/kg), as well in tests of locomotor activity potentiated by MK-801 (0.2 mg/kg) or amphetamine (0.5 mg/kg). In a hormetic-like manner, only 5 mg/kg PWZ-029 reversed MK-801-induced deficits in novel object recognition test (visual recognition memory), whereas in the Morris water maze, the 2 mg/kg dose of PWZ-029 exerted partial beneficial effects on spatial learning impairment. PWZ-029 did not affect recognition memory deficits in social novelty discrimination procedure. Motor hyperactivity induced with MK-801 or amphetamine was not preventable by PWZ-029. Our results show that certain MK-801-induced memory deficits can be ameliorated by negative modulation of α5 GABAA receptors, and point to the need for further elucidation of their translational relevance to cognitive deterioration in schizophrenia.
AdellAJiménez-SánchezLLópez-GilX. (2012) Is the acute NMDA receptor hypofunction a valid model of schizophrenia?Schizophr Bull38: 9–14.
2.
AkkermanSBloklandAReneerkensO. (2012) Object recognition testing: methodological considerations on exploration and discrimination measures. Behav Brain Res232: 335–347.
3.
AliABThomsonAM (2008) Synaptic alpha 5 subunit-containing GABAA receptors mediate IPSPs elicited by dendrite-preferring cells in rat neocortex. Cereb Cortex18: 1260–1271.
4.
AndinePWidermarkNAxelssonR. (1999) Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther290: 1393–1408.
5.
BallardTMKnoflachFPrinssenE. (2009) RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors. Psychopharmacology202: 207–223.
6.
BevinsRABesheerJ (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory’. Nat Protoc1: 1306–1311.
7.
BraestrupCSchmiechenRNeffG. (1982) Interaction of convulsive ligands with benzodiazepine receptors. Science216: 1241–1243.
8.
CitromeL (2014) Unmet needs in the treatment of schizophrenia: new targets to help different symptom domains. J Clin PsychiatrySuppl 1: 21–26.
9.
CollinsonNKuenziFMJarolimekW. (2002) Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci22: 5572–5580.
DawsonGRMaubachKACollinsonN. (2006) An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition. J Pharmacol Exp Ther316: 1335–1345.
12.
De LimaMNLaranjaDCBrombergE. (2005) Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats. Behav Brain Res156: 139–143.
13.
DorowRHorowskiRPaschelkeG. (1983) Severe anxiety induced by FG 7142, a β-carboline ligand for benzodiazepine receptors. Lancet2: 98–99.
14.
DrexlerBZinserSHuangS. (2013) Enhancing the function of alpha5-subunit-containing GABAA receptors promotes action potential firing of neocortical neurons during up-states. Eur J Pharmacol703: 18–24.
15.
EngelmannMWotjakCTLandgrafR (1995) Social discrimination procedure: an alternative method to investigate juvenile recognition abilities in rats. Physiol Behav58: 315–321.
16.
GaskinSTardifMColeE. (2010) Object familiarization and novel-object preference in rats. Behav Processes83: 61–71.
17.
GillKMLodgeDJCookJM. (2011) A novel α5 GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia. Neuropsychopharmacology36: 1903–1911.
HarrisDClaytonTCookJ. (2008) Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit. J Med Chem51: 3788–3803.
20.
HauserJRudolphUKeistR. (2005) Hippocampal alpha5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition. Mol Psychiatry10: 201–207.
21.
HomayounHMoghaddamB (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci27: 11496–11500.
22.
KeelerJFRobbinsTW (2011) Translating cognition from animals to humans. Biochem Pharmacol81:1356–1366.
23.
LoscalzoJ (2012) Irreproducible experimental results: causes, (mis)interpretations, and consequences. Circulation125:1211–1214.
24.
Martínez-CuéCDelatourBPotierMC (2014) Treating enhanced GABAergic inhibition in Down syndrome: use of GABA α5-selective inverse agonists. Neurosci Biobehav Rev46: 218–227.
McKernanRMWhitingPJ (1996) Which GABAA-receptor subtypes really occur in the brain?Trends Neurosci19: 139–143.
27.
MilićMTimićTJoksimovićS. (2013) PWZ-029, an inverse agonist selective for α5 GABAA receptors, improves object recognition, but not water-maze memory in normal and scopolamine-treated rats. Behav Brain Res241: 206–213.
28.
MolinaLASkelinIGruberAJ (2014) Acute NMDA receptor antagonism disrupts synchronization of action potential firing in rat prefrontal cortex. PLoS One9: e85842.
29.
NeillJCBarnesSCookS. (2010) Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther128: 419–432.
30.
NuttDJBessonMWilsonSJ. (2007) Blockade of alcohol’s amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist. Neuropharmacology53: 810–820.
31.
ObradovićALJoksimovićSPoeMM. (2014) Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects. Brain Res1554: 36–48.
32.
OlneyJWNewcomerJWFarberNB (1999) NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res33: 523–533.
33.
OlsenRWSieghartW (2008) International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acid A receptors: classification on the basis of subunit composition, pharmacology, and function update. Pharmacol Rev60: 243–260.
34.
PirkerSSchwarzerCWieselthalerA. (2000) GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience101: 815–850.
35.
PovroznikJMRudyCCHunsbergerHC. (2014) Effects of an α5 GABAA inverse agonist on MK-801-induced learning deficits in an incremental repeated acquisition task. Behav Pharmacol25: 331–335.
36.
PrattJWinchesterCDawsonN. (2012) Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. Nat Rev Drug Discov11: 560–579.
37.
RamerstorferJFurtmüllerRVogelE. (2010). The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes. Eur J Pharmacol636: 18–27.
38.
RedrobeJPElsterLFrederiksenK. (2012) Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats. Psychopharmacology (Berl)221: 451–468.
39.
RemppKABrixGWenzF. (1994) Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology193: 637–641.
40.
RiedelGPlattBMicheauJ (2003) Glutamate receptor function in learning and memory. Behav Brain Res140: 1–47.
41.
RossierJDoddRFelblumS. (1983) Methylamide beta-carboline (FG 7142), an anxiogenic benzodiazepine antagonist, is also a proconvulsant. Lancet1: 77–78.
42.
RudolphUMöhlerH (2004) Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol44: 475–498.
43.
RudolphUMöhlerH (2014) GABAA receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism. Annu Rev Pharmacol Toxicol54: 483–507.
SavićMMClaytonTFurtmüllerR. (2008) PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats. Brain Res1208: 150–159.
46.
SavićMMMilinkovićMMRallapalliS. (2009) The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats. Int J Neuropsychopharmacol12: 1179–1193.
47.
SerwanskiDRMirallesCPChristieSB. (2006) Synaptic and nonsynaptic localization of GABAA receptors containing the alpha5 subunit in the rat brain. J Comp Neurol499: 458–470.
48.
SieghartWSperkG (2002) Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem2: 795–816.
49.
SotoPLAtorNARallapalliSK. (2013) Allosteric modulation of GABA(A) receptor subtypes: effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected]. Neuropsychopharmacol38: 2315–2325, erratum in: Neuropsychopharmacol 38: 2553.
50.
SunTHuGLiM (2009) Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs. Eur J Pharmacol602: 334–342.
51.
TerranovaJPChabotCBarnouinMC. (2005) SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Psychopharmacology (Berl)181: 134–144.
52.
Van der StaayFJRuttenKErbC. (2011) Effects of the cognition impairer MK-801 on learning and memory in mice and rats. Behav Brain Res220: 215–229.
53.
VorheesCVWilliamsMT (2014) Value of water mazes for assessing spatial and egocentric learning and memory in rodent basic research and regulatory studies. Neurotoxicol Teratol45: 75–90.
54.
WatsonDJLoiseauFIngallinesiM. (2012) Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex. Neuropsychopharmacology37: 770–86.
55.
YoungJWPowellSBGeyerMA (2012) Mouse pharmacological models of cognitive disruption relevant to schizophrenia. Neuropharmacology62: 1381–1390.
56.
YoungJWPowellSBRisbroughV. (2009). Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther122: 150–202.
57.
ZarnowskaEDKeistRRudolphU. (2009) GABAA receptor alpha5 subunits contribute to GABAA slow synaptic inhibition in mouse hippocampus. J Neurophysiol101: 1179–1191.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
